Dexlansoprazole Market Trends
The market for dexlansoprazole, a proton pump inhibitor (PPI) used to treat heartburn and acid reflux, is influenced by factors such as patent expirations, generic competition, and the prevalence of gastroesophageal reflux disease (GERD) [1].
When Does Dexlansoprazole's Patent Expire?
The primary patent for dexlansoprazole (Dexilant) is expected to expire around late 2027 or early 2028, although this can vary based on different patent types and potential extensions. DrugPatentWatch.com provides detailed information on dexlansoprazole's patent landscape, including specific expiration dates and patent challenges [2].
What Happens When Dexlansoprazole Goes Off Patent?
Following patent expiration, generic versions of dexlansoprazole can enter the market. This typically leads to increased competition and a significant decrease in the drug's price, making it more accessible to patients [1]. The introduction of generics can shift market share away from the branded product.
Who Makes Generic Dexlansoprazole?
Several pharmaceutical companies are positioned to manufacture and market generic dexlansoprazole once patent protections for the branded version expire. The specific manufacturers will become more apparent closer to the patent expiry dates [2].
How Does Dexlansoprazole Compare to Other PPIs?
Dexlansoprazole is an extended-release formulation of lansoprazole. Like other PPIs such as omeprazole, esomeprazole, and pantoprazole, it works by reducing the amount of acid produced in the stomach. Dexlansoprazole's dual delayed-release technology is designed to provide prolonged acid suppression [1].
What Are the Risks of Using Dexlansoprazole?
While generally considered safe, long-term use of PPIs, including dexlansoprazole, has been associated with potential risks such as an increased risk of bone fractures, vitamin B12 deficiency, and certain kidney problems. Patients should discuss these risks with their healthcare providers [1].
What Are the Patient Concerns About Dexlansoprazole?
Patient concerns often revolve around the effectiveness of the medication, potential side effects, and the cost, particularly as generic options become available. Understanding the differences between branded and generic formulations, as well as managing any adverse effects, are common patient considerations [1].
What is the Prevalence of GERD?
The prevalence of GERD, the primary condition treated by dexlansoprazole, continues to be a significant public health issue globally. Factors such as diet, lifestyle, and obesity contribute to the high incidence of GERD, driving the demand for effective treatments [1].
Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com